Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.
Epistemonikos ID: 02dd544f6a63454417ea9f0076612668978ba9ba
First added on: Oct 01, 2024